Search results
ImmunoGen (IMGN) Q3 Loss Wider, Sales Beat, '22 View Up
Zacks via Yahoo Finance· 2 years agoImmunoGen (IMGN) reports a wider-than-expected loss in third-quarter 2022. Nevertheless, it beat...
ImmunoGen (IMGN) Q1 Earnings Beat, Elahere Uptake Encouraging
Zacks via Yahoo Finance· 1 year agoImmunoGen (IMGN) reports impressive Q1 earnings results on strong adoption of sole-marketed drug...
ImmunoGen (IMGN) Gets Accelerated FDA Approval for Ovarian Cancer Drug
Zacks via Yahoo Finance· 2 years agoImmunoGen (IMGN) receives accelerated FDA approval for its lead drug mirvetuximab soravtansine-gynx,...
ImmunoGen (IMGN) Enters New Collaboration to Boost ADC Pipeline
Zacks via Yahoo Finance· 2 years agoImmunoGen (IMGN) inks a collaboration deal with privately-held Oxford BioTherapeutics to develop...
Institutional investors in ImmunoGen, Inc. (NASDAQ:IMGN) lost 9.0% last week but have reaped the...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Given the large stake in the stock by institutions, ImmunoGen's stock price might be...
ImmunoGen (IMGN) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoImmunoGen (IMGN) delivered earnings and revenue surprises of -19.23% and 30.16%, respectively, for...
ImmunoGen (IMGN) Stock Surges 230% in a Month: Here's Why
Zacks via Yahoo Finance· 1 year agoImmunoGen (IMGN) shares surge exponentially in the past month owing to the positive data on the...
ImmunoGen (IMGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Zacks via Yahoo Finance· 10 months agoImmunoGen (IMGN) possesses the right combination of the two key ingredients for a likely earnings...
When Will ImmunoGen, Inc. (NASDAQ:IMGN) Turn A Profit?
Simply Wall St. via Yahoo Finance· 7 months agoWith the business potentially at an important milestone, we thought we'd take a closer look at...
ImmunoGen (IMGN) Down 16.6% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for ImmunoGen (IMGN). Shares have lost about...